David Rescott

Stock Analyst at Baird

(3.55)
# 840
Out of 4,876 analysts
60
Total ratings
55.1%
Success rate
4.71%
Average return

Stocks Rated by David Rescott

Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $74.77
Upside: +16.36%
Medtronic
May 22, 2025
Maintains: Neutral
Price Target: $94$92
Current: $86.18
Upside: +6.75%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55$61
Current: $45.83
Upside: +33.12%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$110
Current: $92.80
Upside: +18.53%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $315$330
Current: $253.58
Upside: +30.14%
Edwards Lifesciences
Apr 24, 2025
Maintains: Neutral
Price Target: $72$75
Current: $77.15
Upside: -2.79%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $115$120
Current: $104.58
Upside: +14.74%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600$575
Current: $534.19
Upside: +7.64%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25$26
Current: $18.09
Upside: +43.73%